NanoViricides
NNVC
#10259
Rank
NZ$32.9 M
Marketcap
NZ$1.52
Share price
-4.06%
Change (1 day)
-26.15%
Change (1 year)

NanoViricides (NNVC) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$2.07 Million

According to NanoViricides's latest financial reports the company's total liabilities are NZ$2.07 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NanoViricides - Total liabilities on balance sheet (from 2006 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-06-30NZ$2.14 M-3.74%
2024-06-30NZ$2.22 M-32.83%
2023-06-30NZ$3.31 M401.32%
2022-06-30NZ$0.66 M31.82%
2021-06-30NZ$0.5 M-84.99%
2020-06-30NZ$3.34 M-21.1%
2019-06-30NZ$4.23 M225.29%
2018-06-30NZ$1.3 M-85.73%
2017-06-30NZ$9.12 M-52.06%
2016-06-30NZ$19.03 M4.19%
2015-06-30NZ$18.27 M-21.86%
2014-06-30NZ$23.38 M115.45%
2013-06-30NZ$10.85 M389.43%
2012-06-30NZ$2.21 M212.85%
2011-06-30NZ$0.7 M-80.18%
2010-06-30NZ$3.57 M344.56%
2009-06-30NZ$0.8 M-40.27%
2008-06-30NZ$1.34 M21.81%
2007-06-30NZ$1.1 M-55.1%
2006-06-30NZ$2.46 M2451.37%
2005-06-30NZ$0.09 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
NZ$63.76 B 3,078,833.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$147.48 B 7,121,408.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$125.28 B 6,049,680.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$106.52 B 5,143,769.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ$2.28 B 110,207.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$1.10 B 53,461.94%๐Ÿ‡บ๐Ÿ‡ธ USA